Now showing items 1-1 of 1

    • Nogales-Gaete, Jorge; Aracena, Rodrigo; Cepeda-Zumaeta, Sergio; Eloiza, Claudio; Agurto, Paula; Díaz, Vannia; Labbé, Silvia; Martínez, Séfora; Flores, Jazmín; Araya, Casandra (Sociedad Medica de Santiago, 2014)
      Background: Immunomodulatory drugs (IMD), Interferon β1a, β1 b and glatiramer acetate are available in the Chilean public health system since June 2008 for patients with relapsing-remitting multiple sclerosis (RR-MS). ...